More Problems at Theranos

Excerpts from various media coverage regarding US regulators saying that a Theranos lab poses an “immediate jeopardy” to patient safety — and a statement from Theranos: Forbes: Some Theranos Tests ‘Pose Immediate Jeopardy To Patient Health And Safety’ “A letter sent to Theranos by U.S. regulators says problems with the company’s blood tests “pose immediate jeopardy […]

Read More

PAIN Q&A – The Big3Bio Interview and Event Preview

Hydra Biosciences, a Cambridge company leading the field in Transient Receptor Potential (TRP) ion channel modulation for pain, inflammation, renal disease, anxiety and pulmonary disease, is hosting a panel discussion entitled “PAIN: a conversation.” Taking place at The Liberty Hotel in Boston from 6 p.m. to 9 p.m. on Thursday, Oct. 22, the event will […]

Read More

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part […]

Read More

The Fascinating Saga of Elizabeth Holmes

From Nuviun.com: “In a 3-part series, Gisele Waters dives into the amazing world of Elizabeth Holmes, and the paradigm shift that her company, Theranos, is beginning to make around the consumerization of healthcare.” An excerpt: “Elizabeth Holmes has stealthily and steadily set up an operations infrastructure to make one of the biggest impacts on healthcare and […]

Read More